FDA inspection
Xinjiang Nuziline Biopharmaceutical Co., Ltd.: FDA inspection ending Nov 11, 2016
FDA inspection 998358 · Voluntary Action Indicated (VAI) · Xinjiang
Key facts
| Inspection ID | 998358 |
|---|---|
| Firm | Xinjiang Nuziline Biopharmaceutical Co., Ltd. |
| FEI number | 3010738916 |
| Address | 252 Km 218 State Rd, Ili Kazakh Autonomous Prefecture |
| City | Xinjiang |
| Country | China |
| Fiscal year | 2017 |
| Inspection end date | Nov 11, 2016 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data